NC
TWST icon

nVerses Capital’s Twist Bioscience TWST Stock Holding History

nVerses Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
+3,132
New +$204K 0.5% 41

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

nVerses Capital's TWST Position: Q2 2026 in Review

nVerses Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 3,132 shares worth $322K. The stake represents 0.5% of the portfolio and ranks #41 among its holdings.

238 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • nVerses Capital held 3,132 shares of Twist Bioscience worth $322K as of Q2 2026.
  • Twist Bioscience was a new nVerses Capital position in Q2 2026.
  • Twist Bioscience made up 0.5% of nVerses Capital's portfolio in Q2 2026, its #41 holding.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.